1. Home
  2. EHTH vs MXCT Comparison

EHTH vs MXCT Comparison

Compare EHTH & MXCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo eHealth Inc.

EHTH

eHealth Inc.

HOLD

Current Price

$1.57

Market Cap

104.0M

Sector

Finance

ML Signal

HOLD

Logo MaxCyte Inc.

MXCT

MaxCyte Inc.

HOLD

Current Price

$1.22

Market Cap

93.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EHTH
MXCT
Founded
1997
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Specialty Insurers
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
104.0M
93.0M
IPO Year
2006
2021

Fundamental Metrics

Financial Performance
Metric
EHTH
MXCT
Price
$1.57
$1.22
Analyst Decision
Hold
Buy
Analyst Count
3
4
Target Price
$3.33
$5.50
AVG Volume (30 Days)
308.7K
1.2M
Earning Date
05-06-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
71.43
N/A
EPS
N/A
N/A
Revenue
$251,395,000.00
$33,026,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$5.60
$18.50
P/E Ratio
N/A
N/A
Revenue Growth
45.86
N/A
52 Week Low
$1.20
$0.64
52 Week High
$5.89
$2.40

Technical Indicators

Market Signals
Indicator
EHTH
MXCT
Relative Strength Index (RSI) 38.74 72.82
Support Level $1.21 $0.72
Resistance Level $1.58 $1.75
Average True Range (ATR) 0.10 0.09
MACD -0.04 0.02
Stochastic Oscillator 14.86 91.77

Price Performance

Historical Comparison
EHTH
MXCT

About EHTH eHealth Inc.

eHealth Inc is a company involved in private health insurance marketplace with a technology and service platform that provides consumer engagement, education and health insurance enrollment solutions. The company operates its business in two segments: Medicare which provides health insurance plans and lesser extent ancillary products such as dental and vision insurance and hospital indemnity plans, to medicare eligible consumers; and Employer and Individual provides individual and family health insurance, and small business health insurance plans and Individual Coverage Health Reimbursement Arrangements. It derives maximum revenue from Medicare Segment. All of the company's revenue is from the United States. It also has a presence in China.

About MXCT MaxCyte Inc.

MaxCyte Inc is a life sciences company focused on advancing the discovery, development, and commercialization of next-generation cell therapies. It uses its proprietary cell engineering technology platform to support biotechnology and pharmaceutical customers in cell therapy, gene editing, immuno-oncology, and biologic development. It operates in one segment: cell engineering technology, which generates revenue mainly from product sales, licenses, research and clinical license fees, and program-related revenues as its SPL customers achieve development and regulatory milestones. Its platform, the ExPERT Platform, is based on Flow Electroporation technology designed to efficiently and safely modify human cells with high efficiency, low cytotoxicity, and scalability for clinical use.

Share on Social Networks: